TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A 2024 Cochrane review found zinc may shorten common-cold symptoms by around two days, but the evidence was rated low-certainty and did not show convincing reductions in overall symptom severity. Dietitian Johannah Katz says lozenges started early may help, while high doses can cause side effects and exceed recommended intake limits.
Zinc may shorten a common cold by around two days when taken after symptoms begin, according to a 2024 Cochrane review cited by registered dietitian Johannah Katz. The finding is not conclusive: reviewers rated the evidence as low-certainty, and they found no convincing evidence that zinc substantially reduces the overall severity of symptoms.
Katz said the evidence appears more relevant to short-term use after a cold starts than to taking zinc routinely as an immune supplement. She said the studies suggest starting as early as possible, ideally within 24 hours of the first symptoms. The review’s estimate of about two days refers to symptom duration, not a guarantee that an individual cold will end sooner.
The source report also cites a meta-analysis of seven trials that found zinc lozenges containing more than 75 milligrams shortened colds by an average of 33% compared with placebo. That result is tied to the trials and products included in that analysis; it does not establish that every zinc product or dose has the same effect. Katz said evidence for lozenges is better than for swallowed tablets and that trials have examined both zinc acetate and zinc gluconate.
Researchers have proposed that zinc released as a lozenge dissolves in the mouth and throat could affect how cold viruses spread or replicate. The source report says this possible local effect has not been confirmed. Katz advised looking at the amount of elemental zinc listed, rather than the total weight of the zinc compound. She also warned against zinc sprays or gels used in the nose, which have been linked to potentially permanent loss of smell.
The Possible Benefit Comes With Limits
Colds have no cure, so evidence that a treatment might shorten symptoms can be relevant to people seeking relief. But the review’s estimate should be read as a possible average effect, not a promise. Its low certainty and the lack of convincing evidence for reduced overall symptom severity mean the research does not establish zinc as a dependable way to feel substantially better.
Safety is a central part of the decision. Katz said trials reporting benefits commonly used about 75 to 90 milligrams of elemental zinc daily, generally for less than two weeks. Those amounts exceed the US adult tolerable upper intake level of 40 milligrams a day, which includes zinc from food and supplements. The source report also notes that UK NHS guidance advises adults not to take more than 25 milligrams of zinc supplements daily unless a doctor advises otherwise. The limits differ by guidance and jurisdiction, so readers should not treat trial doses as general instructions.
Katz listed nausea, stomach upset and an unpleasant or metallic taste among common side effects. She also warned that prolonged high-dose use can interfere with copper absorption and may impair immune function. Zinc can interact with tetracycline and quinolone antibiotics and penicillamine, so the possible short-term benefit has to be weighed against a person’s health circumstances, other medicines and the dose involved.
As an affiliate, we earn on qualifying purchases.
What the Zinc Studies Examined
Zinc is an essential mineral that supports normal immune function. The source report describes it as helping immune cells function and communicate, and helping regulate inflammation. That role does not, on its own, prove that supplements prevent infection or shorten an illness; those questions depend on clinical studies.
The evidence summarized in the report includes the 2024 Cochrane review, which assessed zinc for treating and preventing colds. Katz said the review found a possible reduction in symptom duration but rated certainty low because studies differed in their doses, formulations and designs. It also found no convincing evidence that zinc meaningfully reduced overall symptom severity. For prevention, she said the review suggested zinc may have little or no effect on the likelihood of developing a cold.
The report separately cites a meta-analysis of seven trials of lozenges containing more than 75 milligrams of zinc. Those findings and the Cochrane review are not interchangeable: they draw on different study sets and measures. Katz’s account supports a cautious distinction between a possible treatment effect after symptoms begin and taking zinc routinely to prevent colds.
Dose, Formulation and Benefit Remain Unsettled
The source report does not provide enough detail to establish which specific lozenge product, dose schedule or patient group is most likely to benefit. Katz said study designs and formulations varied, and the mechanism by which zinc might affect cold viruses has not been confirmed. The reported average reductions also cannot predict how long an individual person’s symptoms will last.
It is also unclear how well the findings apply to people with particular health conditions, those taking interacting medicines, or users of products that differ from those tested. The report does not describe a new study or identify a single dose that can be recommended for everyone. Its cited trial doses exceed some public-health intake limits, making professional guidance relevant before high-dose use.
Check Guidance Before Taking High Doses
The findings described here are a summary of existing research, not a new clinical announcement. Readers considering zinc for a cold should check product labels and local health guidance, and speak with a pharmacist or healthcare professional before using high doses—particularly if they take prescription medicines or have other health concerns. The source report gives no timetable for additional research or a change in official guidance.
Further studies would need to clarify which formulations and doses, if any, reliably shorten symptoms, how soon treatment must begin, and how benefits compare with side effects. Until then, the evidence supports describing zinc lozenges as a possible modest aid, not a proven way to end a cold or a routine preventive measure.
Key Questions
Does zinc cure the common cold?
No. The source report says there is no cure for the common cold. Research suggests zinc may shorten symptoms in some circumstances, but the evidence is uncertain and does not guarantee recovery sooner.
How much sooner might a cold end with zinc?
The 2024 Cochrane review cited in the report found zinc may shorten symptoms by around two days. Reviewers rated the evidence low-certainty, so this is an estimate, not a promise for an individual.
Which kind of zinc did the report say has better evidence?
Dietitian Johannah Katz said the evidence is better for zinc lozenges than for swallowed tablets. She said both zinc acetate and zinc gluconate lozenges have shown benefit, but the research does not establish that all products work equally well.
Are the doses used in studies safe to take without advice?
Katz said trials reporting benefits commonly used roughly 75 to 90 milligrams of elemental zinc daily, amounts above the US adult upper intake level of 40 milligrams a day. UK NHS guidance cited in the report advises no more than 25 milligrams of zinc supplements daily unless a doctor advises otherwise. Ask a pharmacist or healthcare professional before taking high doses, especially if you use medicines.
Should zinc be taken to prevent a cold?
The report says the latest Cochrane review found preventive zinc supplementation may have little or no effect on the likelihood of getting a cold. Katz described the evidence as stronger for short-term use after symptoms begin, though that benefit remains uncertain.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
